Astrana Health EV/EBIT ASTH

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2019.

Today, Oct 23, 2026: 26.2×
8-year median: 22.2×
Against its 8-year history: 73rd; percentile: 0 is its lowest day, 100 its highest
8-year range: 6.0× to 63.0×
Peer median: 14.8×

Astrana Health's EV/EBIT is 26.2× as of Oct 23, 2026.

That is above its 8-year median of 22.2×, higher than on 73% of days in the last 8 years.

Over that time it ranged from 6.0× in Mar 2019 to 63.0× in Jul 2021.

The median for 9 consulting Services stocks of a similar size is 14.8×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	26.2×	24.5×	38.2×
2025	33.4×	17.2×	33.4×
2024	22.7×	19.7×	36.8×
2023	21.5×	14.6×	21.5×
2022	15.3×	14.7×	26.3×
2021	32.3×	16.5×	63.0×
2020	14.0×	13.3×	29.7×
2019	24.3×	6.0×	24.8×

Against its peers

Companies in Consulting Services nearest Astrana Health's size, closest first, today.

Company	EV/EBIT
ASTHAstrana Health	26.2×
ICFIICF International	14.8×
HURNHuron Consulting	20.8×
EXPOExponent	29.0×
FCNFTI Consulting	13.7×
BWMNBowman Consulting	43.9×
GGenpact LTD	9.5×
BAHBooz Allen Hamilton	11.9×
HCKTHackett	10.3×
IIIInformation Services	16.2×
Peer median	14.8×

Where Astrana Health ranks

#12of 16Consulting Services stocks with the lowest EV/EBIT

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Astrana Health

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.